Skip to main content

Table 3 High-pressure liquid chromatography analysis of palmitoylethanolamide content in different commercially available palmitoylethanolamide products a

From: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain

  Normast 300 mg (tablet) Normast 600 mg (tablet) Normast 600 mg (microgranular) PeaPure PeaVera Peanase Sinerga
Supplier Epitech Group Epitech Group Epitech Group JP Russell JP Russell LJ Pharma Galsor
Lot no. D09813 D012A4 D067F3 12126A 14A09H SK629 11283
PEA content/dose claimed 300 mg 600 mg 600 mg 400 mg 400 mg 300 mg 150 mg
PEA content found 300.8 mg 611.5 mg 614.5 mg 344.7 mg 347.8 mg 248.5 mg 71.4 mg
  1. aPEA-m, Micronized palmitoylethanolamide; PEA-um, Ultramicronized palmitoylethanolamide. Values exceeding 100% are due to the precision of the analytical methods used. Assay specification limits are 98% to 102%.